If Anavex raises capital expecting that they will withdraw their MAA, they would open themselves up to a shareholder class action suit.
Quite an imagination! Misleading don't care about any lawsuits, he only cares about his pocket. Nasdaq is littered with scam baby biotechs — CEOs dilute the stock and release negative news the next day. A recent example is INMB.
Market Data 
Markets 
AI
